Por favor, tente outra busca
Nome | Idade | Desde | Título |
---|---|---|---|
Sharon G. Adler | - | - | Member of Scientific Advisory Board |
Stephen C. Glover | 63 | 2022 | Co-Founder, Chairman, CEO & President |
Pablo A. Guzman | 73 | 2023 | Chief Medical Officer, Senior VP of Medical Affairs & Chairman of Renal Scientific Advisory Board |
Min-Chul Park | 41 | 2022 | Independent Director |
Robert W. Keane | - | - | Member of Scientific Advisory Board |
Douglas H. Farrar | 58 | - | Member of Scientific Advisory Board |
Alan C. Herman | 75 | - | Member of Scientific Advisory Board |
William F. Bennett | 74 | - | Member of Scientific Advisory Board |
Robert G. Finizio | 52 | 2022 | Independent Director |
Miguel S. Barbosa | 65 | - | Member of Scientific Advisory Board |
Marlene Haffner | 82 | - | Member of Scientific Advisory Board |
Fernando C. Fervenza | - | - | Member of Renal Scientific Advisory Board |
W. Dalton Dietrich | 70 | - | Member of Scientific Advisory Board |
Daniel G. Baker | - | - | Member of Scientific Advisory Board |
James R. Sapirstein | 62 | 2023 | Independent Director |
Gregory G. Freitag | 61 | 2023 | Independent Director |
Nicholas A. LaBella | 67 | 2022 | Member of Scientific Advisory Board |
Juan Pablo de Rivero Vaccari | - | - | Member of Scientific Advisory Board |
Alessia Fornoni | - | - | Member of Scientific Advisory Board |
Helen Bramlett | - | - | Member of Scientific Advisory Board |
Daniel C. Cattran | - | - | Member of Renal Scientific Advisory Board |
Richard J. Glassock | - | 2023 | Member of Renal Scientific Advisory Board |
Douglas T. Golenbock | - | 2023 | Member of Scientific Advisory Board |
Tem certeza de que deseja bloquear %USER_NAME%?
Ao confirmar o bloqueio, você e %USER_NAME% não poderão ver o que cada um de vocês posta no Investing.com.
%USER_NAME% foi adicionado com êxito à sua Lista de bloqueios
Já que acabou de desbloquear esta pessoa, você deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou desse comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão